To explore the hypothesis that mental retardations are in part genetotrophic diseases (diseases in which the genetic pattern of the afflicted individual requires an augmented supply ofone or more nutrients such that when these nutrients are adequately supplied the disease is ameliorated), we carried out a partially double-blind experiment with 16 retarded children (initial IQs, -17-70) of school age who were given nutritional supplements or placebos during a period of 8 months. The supplement contained 8 minerals in moderate amounts and 11 vitamins, mostly in relatively large amounts. During the first 4-month period (double-blind) the 5 children who received supplements increased their average IQ by 5.0-9.6, depending on the investigator, whereas the 11 subjects given placebos showed negligible change. The difference between these two groups is statistically significant (P < 0.05). Durin the second period, the subjects who had been given placebos in the first study received supplements; they showed an average IQ increase of at least 10.2, a highly significant gain (P < 0.001). Three of the five subjects who were given supplements for both periods showed additional IQ gains during the second 4 months. Three of four children with Down syndrome gained between 10 and 25 units in IQ and also showed physical changes toward normal. Other evidence suggests that the supplement improved visual acuity in two children and increased growth rates. These results support the hypothesis that mental retardations are in part genetotrophic in origin.
About 30 years ago Williams and coworkers (1, 2) formulated the concept ofgenetotrophic disease. A genetotrophic disease is one in which, because of his genetic nature, the afflicted person requires an augmented supply of one or more specific nutrients and in which fulfilling these needs prevents or at least ameliorates the disease.
The genetotrophic hypothesis was in mind when G. S., a severely retarded child, was treated by the senior author. When first seen, the patient was 7 years old and in diapers, could not speak, and had an estimated IQ of25-30. At her instigation, his blood and tissues were analyzed in the laboratories of Mary B.
Allen, a biochemist in Richmond, VA. With the cooperation of a physician, Allen devised a nutritional supplement and G. S. 's parents agreed to administer it. There were no noticeable results for several weeks, but after some constituents of the supplement were increased G. S. suddenly began to improve. In a few days he was talking a little; in a few weeks he was learning to read and write, and he began to act like a normal child. When G. S. was 9 years old he read and wrote on the elementary school level, was moderately advanced in arithmetic, and, according to his teacher, was mischievous and active. He rode a bicycle and a skate board, played ball, played a flute, and had an IQ ofabout 90. It appeared that, even after 7 years of deprivation, G. S. responded to some nutrients in the supplement in a remarkable fashion. His case seemed to support the genetotrophic hypothesis as applied to mental retardation.
On the basis ofG. S. 's remarkable response and the somewhat less striking responses ofseveral others, we decided to carry out a controlled study ofchildren classified as retarded (IQ less than 75).
EXPERIMENTAL
Plan. Allen died in 1977. From her records and the laboratory records in our own file it became evident that her subjects showing mental response were those given a supplement similar to that given G. S. We decided to give our subjects this supplement, consisting of 11 vitamins and 8 minerals as shown in Table 1 .
We also decided to include in the program ofsupplements, as Allen frequently did, extra thyroid hormone for those children found to be in need of it. All subjects except one were found to 
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RESULTS
Intelligence Quotients. Table 2 lists all the IQ measurements obtained for the 16 subjects who completed the first 4-month period. Proc. Nad Acad. Sci. USA 78 (1981) Proc. NatL Acad. Sci. USA 78 (1981) 577 points), and we hesitate to emphasize this analysis on the basis ofour limited study.
Heights and-Weights. In both groups, during their first 4 months ofsupplementation the children gained in height on the average more than twice as much as did the group II subjects on placebo: 2.13 ± 0.64 cm in 4 months for 14 measured subjects vs. 0.89 ± 0.43 cm in 4 months for 11 subjects (means ± SEM). Weight changes were too irregular to be meaningful.
Urinalyses. Routine urinalyses made by the Department of Pathology of Norfolk General Hospital at 4-month intervals were monitored by two ofus (J.P. and L.R.R.). All values ofpH, specific gravity, protein, and blood cell counts were normal.
Electroencephalograms. Two encephalographers at the same hospital, James E. Ethridge, Jr., and one of us (L.R.R.), found no changes that could be correlated with the regimen of supplements.
Visual Acuity. During the second or third mental testing periods, one of us (R.F. H.) noted that three of the four subjects who wore glasses (J.B., S.R., and C. D.) removed their glasses when they wished to see the task at hand clearly. After the code was broken she found that in each case this observation was made after the child had received supplements for 4 months. Subsequently, two of the children (S.R. and C. D.), long accustomed to wearing glasses, were advised by their ophthalmologists to discontinue wearing them.
One child (S.R.), a 9-year-old girl with Down syndrome, developed cataracts which were discovered by her ophthalmologist at about the time the experiment began. S.R. received supplements throughout the experiment. At 6-week intervals the ophthalmologist examined S.R.'s eyes for growth of the cataracts. After 8 months, near the study's end, he reported the condition as "stabilized, not worsening, notprogressing as most cataracts do." This finding is consistent with earlier findings in humans (4) and in animals (5) that cataracts may be prevented or delayed by nutritional improvements.
Improvements in Down Syndrome. The children with Down syndrome were the only ones whose physical appearance changed notably during the study. These changes were noted by the principal investigator and by the parents and were visible in photographs taken ofthe subjects at 4-month intervals. Three of these children (C. D., S. R., and L.A.) tended to lose the accumulated fluid in their faces and extremities. The largest IQ gain observed (25 units) occurred in L.A. after 8 months of supplementation. The lone drop-out during the second period (E. H.) occurred because the parents were unprepared for the changes in the formerly docile subject's personality.
Other Effects. Several children improved greatly in school achievement. For example, J. B. (age 5-6), who said only single words such as "Mama" or "bye-bye" initially, could recite without prompting the Pledge of Allegiance after 8 months of supplementation and could read the first-grade primer. Two (T.C. and R. S.) have been transferred from programs for the mentally retarded to regular schools and grades, on their teachers' recommendations. There were no unfavorable side effects noted or brought to our attention in any ofthe children. There were some favorable reports on improved texture of finger nails, healthier hair or skin, and (in six cases) cessation ofhyperactivity.
DISCUSSION
The concept of genetotrophic disease prompted the clinical trials that led to this exploratory study. According to this concept, maladies of many sorts may be caused by genetically determined insufficiencies that may be prevented or at least ameliorated by an augmented supply of one or more specific nutrients.
There are a number ofwell-recognized genetic diseases that clearly are genetotrophic in origin, in particular several diseases that respond to increased intakes ofvitamin B6 (6) or ofvitamin D or its metabolites (7) . In some cases the augmented supply of nutrients appears to enhance the impaired activity of defective enzymes that use vitamin B6 as a cofactor or to increase the availability of biochemically active derivatives of vitamin D. In view of the ubiquitous occurrence of biochemical individuality (2) , including the vast amount of genetic variability that is detectable in humans and in other species by protein electrophoresis (8) , it seems likely that the currently recognized examples ofgenetotrophic disease represent only the most simple and obvious members ofa large class.
Although none of our 15 subjects given supplements responded as spectacularly as did G. S., and further studies are required, our exploratory double-blind study supports the hypothesis that mental retardations in part have genetotrophic origins and that suitable nutritional intervention can improve the IQ and functioning of severely retarded children. All ofour subjects who cooperated in taking the supplements showed improvement, sometimes dramatic and surprising to the teachers and~other professionals who dealt with them. Ifour findings are confirmed by more extensive experiments, they bring new hope for improving the quality of life for the mentally retarded 3.2% ofour population.
We hope that our results will attract other competent investigators to this field and that nutritional studies to explore the prevention and treatment of mental retardation will become commonplace. There are many questions such as the effects of age, initial IQ, type of retardation, and characteristics of the supplementation that can be answered only by more extensive studies.
It is likely, on theoretical grounds and on the basis ofour evidence of a correlation with age, that the earliest possible use of supplementation for potentially retarded children will bring the greatest improvements. Prenatal supplementation should be considered in this connection.
It seems certain that better supplements can be found than the particular combination we tested. Our supplement includes no provision for anyone who needs augmented intakes ofthe individual essential amino acids, choline (9), fatty acids, biotin, vitamin K, or trace minerals such as chromium, selenium, or molybdenum. And it fails to provide normal metabolites or food factors that ordinarily are not dietary essentials, such as vitamin metabolites, glutamine (10, 11) and other "nonessential" amino acids, inositol, pangamic acid, and coenzyme Q. All of these items must be considered in any thorough attempt to discover and prevent genetotrophic diseases.
Ultimately it should be possible to tailor supplements to meet individual needs, at which time perhaps several ofthe nutrients we included could be reduced or eliminated in individual cases (different nutrients for different individuals), and even greater amounts of specific nutrients might be called for on an individual basis. This will require long and careful research aimed at answering specific detailed questions.
The administration of a number of drugs at the same time, sometimes referred to as the "shotgun" approach, is a dubious procedure. The administration of several nutrients at the same time should not be confused with this approach because of the scientific fact that a number ofnutrients often do work together as a team to promote normal metabolism (5) . At least until adequate methods become available for assessing the needs of individual mentally deficient children, we suggest that the most rapid and greatest potential benefits for them will come from research using generous, limited-risk supplements at least as broad as the one we tested. The lack of IQ changes in the placebo subjects indicates that, in this experiment, thyroid administration alone had no appreciable effect on IQ.
Related Research. One ofus (R. F. H.) has published several related studies in which children's IQs have been raised slightly by the administration of thiamin (12, 13) and in which the children of pregnant and nursing mothers, given limited supplements had statistically higher IQs measured at age 3 (14) . Hall has reviewed a large number ofsuggestive reports on the effect ofvarious nutrients on subjects with mental retardation or other mental problems (15) . Kubala and Katz (16) found the average IQ score to be 4.5 higher in 72 students with plasma ascorbic acid levels >1.1 mg/ dl than in 72 students matched by socio-economic criteria but with plasma levels <1.1 mg/dl. Most of this difference in IQ was abolished after both groups were given supplemental orange juice for 6 months. From these statistically significant results they concluded that some of the variance in intelligencetest performance is determined by the "temporary nutritional state of the individual, at least with regard to . . . ascorbic acid."
Kershner and Hawke (17) recently studied the effects of an improved diet and four vitamins on the IQ, school achievements, and other measurements in 20 learning-disabled children. For 6 months, large amounts of ascorbic acid, niacinamide, calcium pantothenate, and pyridoxine were given to 10 of the children on a double-blind basis. The improved diet seemed to produce benefits, but the supplement added to the diet produced little additional effect. However, there were suggestive improvements in IQ and in reading tests that occurred only in the group given the supplement.
Several physicians have reported that nutritional supplements help ameliorate Down syndrome, but the reports ofbenefits, including IQ improvements, are difficult to evaluate. Many drugs were used concurrently, and the reports generally lack data or statistical analysis (18, 19) .
